Industry
Nanogen to Merge with Private French Diagnostics Firm
Nanogen, Inc. (San Diego, CA, USA) has announced that it will merge with the private French company Elitech. The combination will create a global provider of products to the molecular, point-of-care, clinical chemistry, and microbiology diagnostics markets with expected first year revenues of more than US$150 million. More...28 Aug 2008
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automated Microscope
dIFine
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
In Other News
Increased Level of Screening Drives Cancer IVD Sector
Invitrogen and Applied Biosystems to Merge in $6.7 Billion Deal
Nanogen to Develop Molecular Diagnostic Test for Influenza
Xceed Grants License for Flow-Thru Chip Technology
PerkinElmer Concentrates Health and Environmental Focus to India
Database Provides Details of India's In Vitro Diagnostics Segment
Leica Microsystems' US Acquisition Expands Histopathology Range
New Clinical Diagnostic Tests to Be Developed
Lab 21 Acquires Independent Clinical Laboratory Diagnostics Company
Sequenom Sells Multiple Mass Array Systems in China
Home Test Confirms Men's Post-Vasectomy Sterility
Invitrogen Licenses Technology for Fluorescent microRNA Labeling Kits
Next-Generation Sequencing Bioinformatics Tools and Resources Developed
Thermo Fisher Scientific Expands Nanoliter Liquid Handling Capabilities
Judge Decides in Favor of Qiagen in Antitrust Claim
New Technology Propels Cell-Based Diagnostics
Beckman Coulter Acquires Rights to Breakthrough Technologies
Advanced Instruments Acquires Manufacturer of Anaerobic Instruments
Fluorotechnics Enters Electrophoresis Market
Molecular Assays To Predict Targeted Cancer Treatment Response
ChanTest Receives Expansion Capital from Ampersand Ventures
Siemens to Supply Amerinet Integrated Automation, Chemistry, and Immunoassays
Qiagen Opens Subsidiary in Hong Kong
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
